17-Allylamino-geldanamycin causes AKT inactivation and enhances the anti-tumor effects of paclitaxel Meeting Abstract


Authors: Solit, D. B.; Basso, A. D.; Munster, P. N.; Norton, L.; Scher, H. I.; Rosen, N.
Abstract Title: 17-Allylamino-geldanamycin causes AKT inactivation and enhances the anti-tumor effects of paclitaxel
Meeting Title: 2001 AACR-NCI-EORTC International Conference - Molecular Targets and Cancer Therapeutics: Discovery, Biology, and Clinical Applications
Journal Title: Clinical Cancer Research
Volume: 7
Issue: 11 Suppl.
Meeting Dates: 2001 Oct 29-Nov 2
Meeting Location: Miami Beach, FL
ISSN: 1078-0432
Publisher: American Association for Cancer Research  
Date Published: 2001-11-01
Start Page: 3740s
Language: English
ACCESSION: WOS:000172121800424
PROVIDER: wos
PUBMED: 11727717
Notes: Meeting Abstract: 430 -- Source: Wos
Citation Impact
MSK Authors
  1. Andrea D. Basso
    32 Basso
  2. Larry Norton
    758 Norton
  3. Neal Rosen
    425 Rosen
  4. David Solit
    779 Solit
  5. Pamela Munster
    30 Munster
  6. Howard Scher
    1130 Scher